MVT: In the News

Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of Timothy...

ImaRx Investments, LLC, an investment firm based in Tucson, Arizona, has received ISO-7 certification on February 1st for its GMP...

Microvascular Therapeutics (MVT) has entered into a licensing agreement with the University of North Carolina at Chapel Hill and Columbia...

Tucson, Arizona, August 1st, 2020: Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a...

Tucson, Arizona, July 22nd, 2020: Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a...

Microvascular Therapeutics (MVT), LLC, a privately-held Tucson-based biotechnology company, has licensed a patent from Triangle...

Microvascular Therapeutics (MVT), a Tucson based biotechnology company, announced that it has been awarded a $1.7M grant from the...

READ PATENT >